Applied Filters:  
Reset Filters

1 - 1 of 1 results for Pump IV Equipment in Cyprus | Medical Devices

P-MediCyp Ltd

P-MediCyp Ltd Logo
Location: Paphos, Cyprus
Business Type: Supplier
P-MediCyp Ltd is a market-driven , medical technology based company, with the mission to launch, market and distribute unique and innovative Health Care, HomeCare, Wellness and wide variety of better life products in Cyprus, Europe Our wide array ...
View Contact Details

Pump IV Description:

In the MedWOW’s catalog, Pump IV is described as follows:
Patient-controlled analgesic infusion pumps.
The above ads list companies that sell and / or service Pump IV.

Pump IV may also be referred to as:

Analgesia Unit, Intravenous | Epidural Analgesia Unit | Infusion Pump, Demand Analgesia | Infusion Pump, Patient-Controlled Analgesic | Intrathecal Analgesia Unit | Pain Control Infusion Pump | Pain Control Syringe Pump | Patient-Controlled Analgesia Unit | Patient-Controlled Analgesic Pump | PCA Pump | Syringe Pump

Pump IV can be found under the following headings:

Home Care | Nursing Services | Intensive Care Unit

Tips for buying Pump IV

  • Some manufacturers of intravenous analgesia units offer prefilled reservoirs, which are usually more expensive than reservoirs filled by the pharmacy, but can be useful in small pharmacies with limited staff, and may also help avoid human errors and accidents associated with filling and labeling reservoirs.
  • Some pain control syringe pumps allow the use of larger reservoirs, which may require less frequent reservoir changes.
  • Facilities need to make sure they do not stock extension sets without a pressure-activated valve in clinical locations where PCA pumps are used.
  • The key issue of assessment for free-flow protection should be to determine if a tubing set is protected rather than whether a particular patient-controlled analgesic pump model is acceptable.
  • For most patient-controlled analgesic pump models, free flow protection depends on the use of tubing with an integral pressure activated valve, to connect the pump reservoir to the patient catheter. This valve should allow fluid to flow to the patient only when enough positive pressure is generated by the pump to open the valve.
  • Facilities should consider the ease of transport before purchasing. To facilitate transportation of epidural analgesia units, many suppliers offer specialized bags or pouches.
  • Occlusion alarm should be sound at >=6 psi. If complete occlusion occurs, the patient-controlled analgesic pump should alarm within three dose activations at every dose-volume setting.
  • Audible alarms or indicators should alert patients and staff to conditions such as low or depleted battery, occlusion, near end of infusion.
  • Antisiphon valves should accompany intravenous analgesia unit pumps using glass syringes to prevent free-flow in case the syringe breaks.
  • Line-powered PCA pumps should be able to charge independent of the main power switch. Epidural analgesia units should automatically switch to battery operation if line power fails, and run for at least 4 hours at the maximum dose rate.
  • PCA pump systems that run entirely off of battery power should have batteries that can last for several days at nominal dose rates.
  • At least a 12-hour therapy should be supported by the dose delivery system, reservoir, and syringe. For home epidural analgesia unit use, longer operating times are preferable.
  • Pain control syringe pumps should be designed to allow clinicians to limit access to the reservoir and controls with a lockbox, combination box, or digital code. Patient-controlled analgesic pumps should allow control of continuous (basal) rate, bolus volume, and time between boluses; the IV pump should be capable of delivery continuously from 0.1 to 99.9 ml/hr.
  • IV Pumps (Pain Control Syringe Pumps) should be able to log up to 200 events including: error codes, alarms, programmed settings, and dose delivery. The data should be retained for at least 1 year. The pain control syringe pump should be able to display dose, concentration, lockout interval, rate, patient requests, and alarm conditions.
  • The dose button on the IV pumps should be easily accessible and located on the bolus cord or pump. The patient should easily activate the dose button, and a recessed button or a double-activation requirement should prevent accidental activation. The PCA pump should acknowledge the request with an audible tone, a tactile response, or a visual display.